Effects of iron-based phosphate binders on mortality and cardiovascular events in patients receiving maintenance dialysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Effects of iron-based phosphate binders on mortality and cardiovascular events in patients receiving maintenance dialysis ; volume:13 ; number:1 ; day:25 ; month:9 ; year:2023 ; pages:1-8 ; date:12.2023
Scientific reports ; 13, Heft 1 (25.9.2023), 1-8, 12.2023
- Creator
-
Tanaka, Akihito
Sasaki, Sho
Noma, Hisashi
Wang, Jui
Onishi, Yoshihiro
Inaguma, Daijo
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-023-43177-9
- URN
-
urn:nbn:de:101:1-2024020515234447185424
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:35 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tanaka, Akihito
- Sasaki, Sho
- Noma, Hisashi
- Wang, Jui
- Onishi, Yoshihiro
- Inaguma, Daijo
- SpringerLink (Online service)
Other Objects (12)
Long-term effects of the iron-based phosphate binder, sucroferric oxyhydroxide, in dialysis patients
Dialysis disequilibrium syndrome induced by neoplastic meningitis in a patient receiving maintenance hemodialysis
IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial
Ferric Citrate, an Iron-Based Phosphate Binder, Reduces Health Care Costs in Patients on Dialysis Based on Randomized Clinical Trial Data
Dialysis Access Maintenance: Plain Balloon Angioplasty
Experience and Daily Burden of Patients with Chronic Kidney Disease Not Receiving Maintenance Dialysis or Renal Transplantation
Author Correction: IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial
Hemorrhagic Cholecystitis in a Patient on Maintenance Dialysis
Association between the Charlson Comorbidity Index and the risk of 30-day unplanned readmission in patients receiving maintenance dialysis
Differential effects of phosphate binders on pre-dialysis serum bicarbonate in end-stage kidney disease patients on maintenance haemodialysis
Phosphate Control: The Next Frontier in Dialysis Cardiovascular Mortality
Cinacalcet studies in pediatric subjects with secondary hyperparathyroidism receiving dialysis
Long-term effects of the iron-based phosphate binder, sucroferric oxyhydroxide, in dialysis patients
Dialysis disequilibrium syndrome induced by neoplastic meningitis in a patient receiving maintenance hemodialysis
IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial
Ferric Citrate, an Iron-Based Phosphate Binder, Reduces Health Care Costs in Patients on Dialysis Based on Randomized Clinical Trial Data
Dialysis Access Maintenance: Plain Balloon Angioplasty
Experience and Daily Burden of Patients with Chronic Kidney Disease Not Receiving Maintenance Dialysis or Renal Transplantation
Author Correction: IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial
Hemorrhagic Cholecystitis in a Patient on Maintenance Dialysis
Association between the Charlson Comorbidity Index and the risk of 30-day unplanned readmission in patients receiving maintenance dialysis
Differential effects of phosphate binders on pre-dialysis serum bicarbonate in end-stage kidney disease patients on maintenance haemodialysis
Phosphate Control: The Next Frontier in Dialysis Cardiovascular Mortality
Cinacalcet studies in pediatric subjects with secondary hyperparathyroidism receiving dialysis
Long-term effects of the iron-based phosphate binder, sucroferric oxyhydroxide, in dialysis patients
Dialysis disequilibrium syndrome induced by neoplastic meningitis in a patient receiving maintenance hemodialysis
IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial
Ferric Citrate, an Iron-Based Phosphate Binder, Reduces Health Care Costs in Patients on Dialysis Based on Randomized Clinical Trial Data
Dialysis Access Maintenance: Plain Balloon Angioplasty
Experience and Daily Burden of Patients with Chronic Kidney Disease Not Receiving Maintenance Dialysis or Renal Transplantation
Author Correction: IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial
Hemorrhagic Cholecystitis in a Patient on Maintenance Dialysis
Association between the Charlson Comorbidity Index and the risk of 30-day unplanned readmission in patients receiving maintenance dialysis
Differential effects of phosphate binders on pre-dialysis serum bicarbonate in end-stage kidney disease patients on maintenance haemodialysis
Phosphate Control: The Next Frontier in Dialysis Cardiovascular Mortality